Follow
Dan Lloyd
Dan Lloyd
Food standards agency
Verified email at food.gov.uk
Title
Cited by
Cited by
Year
Design and Syntheses of Highly Potent Teixobactin Analogues against Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant …
A Parmar, R Lakshminarayanan, A Iyer, V Mayandi, ET Leng Goh, ...
Journal of medicinal chemistry 61 (5), 2009-2017, 2018
902018
The myxobacterium Myxococcus xanthus can sense and respond to the quorum signals secreted by potential prey organisms
DG Lloyd, DE Whitworth
Frontiers in microbiology 8, 233495, 2017
612017
Teixobactin analogues reveal enduracididine to be non-essential for highly potent antibacterial activity and lipid II binding
A Parmar, A Iyer, SH Prior, DG Lloyd, ETL Goh, CS Vincent, ...
Chemical Science 8 (12), 8183-8192, 2017
602017
Syntheses of potent teixobactin analogues against methicillin-resistant Staphylococcus aureus (MRSA) through the replacement of l-allo-enduracididine with its isosteres
A Parmar, A Iyer, DG Lloyd, CS Vincent, SH Prior, A Madder, EJ Taylor, ...
Chemical communications 53 (55), 7788-7791, 2017
432017
Cysteines and disulfide-bridged macrocyclic mimics of teixobactin analogues and their antibacterial activity evaluation against methicillin-resistant Staphylococcus aureus (MRSA)
R Malkawi, A Iyer, A Parmar, DG Lloyd, ET Leng Goh, EJ Taylor, ...
Pharmaceutics 10 (4), 183, 2018
152018
De Novo Resistance to Arg10-Teixobactin Occurs Slowly and Is Costly
DG Lloyd, BJ Schofield, MR Goddard, EJ Taylor
Antimicrobial Agents and Chemotherapy 65 (1), 10.1128/aac. 01152-20, 2020
112020
Stereoselective synthesis of protected l-allo-Enduracididine and l-Enduracididine via asymmetric nitroaldol reaction
K Ohsawa, H Zhao, T Tokunaga, C Thomas, A Ganesan, Y Masuda, T Doi
Synthesis 52 (06), 942-948, 2020
12020
Investigating the potential of pre-clinical cell-wall synthesis inhibiting antibiotics
D Lloyd
University of Lincoln, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–8